True Wealth Design’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.22K Sell
204
-104
-34% -$3.07K ﹤0.01% 1181
2026
Q1
$8.53K Buy
308
+280
+1,000% +$7.19K ﹤0.01% 1030
2025
Q4
$608 Hold
28
﹤0.01% 1889
2025
Q3
$424 Hold
28
﹤0.01% 2060
2025
Q2
$316 Hold
28
﹤0.01% 1914
2025
Q1
$283 Buy
+28
New +$303 ﹤0.01% 1804

Other funds holding ROIV

True Wealth Design's ROIV Position: Q2 2026 in Review

True Wealth Design reduced its Roivant Sciences (ROIV) stake by 34% in Q2 2026, selling an estimated $3.07K and leaving 204 shares worth $7.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1181.

True Wealth Design first reported a position in ROIV in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.53K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • True Wealth Design held 204 shares of Roivant Sciences worth $7.22K as of Q2 2026.
  • True Wealth Design sold 104 Roivant Sciences shares in Q2 2026, an estimated $3.07K.
  • Roivant Sciences made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1181 holding.
  • True Wealth Design first reported a position in Roivant Sciences in Q1 2025 and has held it in 6 quarters since.
  • True Wealth Design's Roivant Sciences position peaked at $8.53K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.